ArteryFlow Technology
PrivateLast Round
Series B
Dec 10, 2021
Total Funding Raised
$21.23M
Company Overview
ArteryFlow Technology operates in Healthcare & Life Sciences and is based in Hangzhou. Its latest recorded funding round was a Series B round in December 2021.
ArteryFlow Technology is a medical technology company that develops intelligent diagnostic and treatment planning solutions for cardiovascular and cerebrovascular diseases using AI and computational fluid dynamics.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Medical Devices, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ArteryFlow Technology Comparables
Compare ArteryFlow Technology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pulse Medical Imaging Technology | 86% | |
| Raysight Medical | 83% | |
| Medis Medical Imaging Systems | 82% |
For institutional investors. Book with your work email.
ArteryFlow Technology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 10, 2021 | ||||
| Series A Extension | Dec 30, 2019 | ||||
| Series A | Sep 6, 2019 | ||||
| Angel | Dec 27, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ArteryFlow Technology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 健壹资本 | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 30, 2023
Grew 133% QoQ, from 9 to 21 employees.
- Dec 30, 2019
$4.3M round with participation from Sinopharm Capital.
For institutional investors. Book with your work email.
ArteryFlow Technology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ArteryFlow Technology's valuation, stock price, and market status.
Is ArteryFlow Technology a public or private company?
ArteryFlow Technology is a private company.
What is the current stock price of ArteryFlow Technology?
ArteryFlow Technology is a private company, so its shares have no public market price. Caplight tracks ArteryFlow Technology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ArteryFlow Technology worth (valuation)?
Valuation information for ArteryFlow Technology is not publicly available.
Can I buy ArteryFlow Technology stock?
ArteryFlow Technology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ArteryFlow Technology's last funding round?
ArteryFlow Technology's most recent funding round was Series B on December 10, 2021.
Who are the main investors in ArteryFlow Technology?
Key investors in ArteryFlow Technology include 健壹资本.
Will ArteryFlow Technology IPO soon?
No public IPO plans have been announced for ArteryFlow Technology.
How can I track ArteryFlow Technology secondary market activity?
Caplight tracks bids, offers, and trades in ArteryFlow Technology's shares on secondary markets.